ES2043012T3 - Derivados de carboxamidas aromaticas y heterociclicas como agentes antineoplasticos. - Google Patents

Derivados de carboxamidas aromaticas y heterociclicas como agentes antineoplasticos.

Info

Publication number
ES2043012T3
ES2043012T3 ES89305141T ES89305141T ES2043012T3 ES 2043012 T3 ES2043012 T3 ES 2043012T3 ES 89305141 T ES89305141 T ES 89305141T ES 89305141 T ES89305141 T ES 89305141T ES 2043012 T3 ES2043012 T3 ES 2043012T3
Authority
ES
Spain
Prior art keywords
derivatives
heterociclic
carboxamides
aromatic
antineoplastic agents
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES89305141T
Other languages
English (en)
Spanish (es)
Inventor
Anton Franz Josef Fliri
Rodney Caughren Schnur
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Corp Belgium
Pfizer Corp SRL
Original Assignee
Pfizer Corp Belgium
Pfizer Corp SRL
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Corp Belgium, Pfizer Corp SRL filed Critical Pfizer Corp Belgium
Application granted granted Critical
Publication of ES2043012T3 publication Critical patent/ES2043012T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/60—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings condensed with carbocyclic rings or ring systems
    • C07D277/62—Benzothiazoles
    • C07D277/68—Benzothiazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
    • C07D277/82—Nitrogen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Steroid Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Graft Or Block Polymers (AREA)
ES89305141T 1988-05-24 1989-05-22 Derivados de carboxamidas aromaticas y heterociclicas como agentes antineoplasticos. Expired - Lifetime ES2043012T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US19803488A 1988-05-24 1988-05-24

Publications (1)

Publication Number Publication Date
ES2043012T3 true ES2043012T3 (es) 1993-12-16

Family

ID=22731735

Family Applications (1)

Application Number Title Priority Date Filing Date
ES89305141T Expired - Lifetime ES2043012T3 (es) 1988-05-24 1989-05-22 Derivados de carboxamidas aromaticas y heterociclicas como agentes antineoplasticos.

Country Status (25)

Country Link
EP (1) EP0343893B1 (esLanguage)
JP (1) JPH0678331B2 (esLanguage)
KR (1) KR910006864B1 (esLanguage)
CN (1) CN1023700C (esLanguage)
AT (1) ATE79114T1 (esLanguage)
AU (1) AU601905B2 (esLanguage)
CA (1) CA1328871C (esLanguage)
DD (1) DD283815A5 (esLanguage)
DE (1) DE68902358T2 (esLanguage)
DK (1) DK249389A (esLanguage)
ES (1) ES2043012T3 (esLanguage)
FI (1) FI892498A7 (esLanguage)
GR (1) GR3005844T3 (esLanguage)
HU (1) HU202507B (esLanguage)
IE (1) IE891667L (esLanguage)
IL (1) IL90337A0 (esLanguage)
MX (1) MX173140B (esLanguage)
MY (1) MY106035A (esLanguage)
NO (1) NO172389C (esLanguage)
NZ (1) NZ229234A (esLanguage)
PL (1) PL154875B1 (esLanguage)
PT (1) PT90622B (esLanguage)
SU (1) SU1681728A3 (esLanguage)
YU (1) YU47019B (esLanguage)
ZA (1) ZA893862B (esLanguage)

Families Citing this family (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2790299B2 (ja) * 1989-02-01 1998-08-27 保土谷化学工業株式会社 ペンゾチアゾール誘導体
US5262400A (en) * 1991-06-20 1993-11-16 Merck & Co., Inc. 4α-substituted avermectin derivatives
US6100423A (en) * 1995-08-30 2000-08-08 G. D. Searle & Co. Amino benzenepropanoic acid compounds and derivatives thereof
MX9801716A (es) 1995-08-30 1998-05-31 Searle & Co Derivados de meta-guanidina, urea, tiourea o acido aminobenzoico azaciclico, como antagonistas de integrina.
US5716281A (en) * 1995-11-27 1998-02-10 Sega Enterprises, Ltd. Game apparatus using a vehicle with an optical image synthesizing system
TW513418B (en) * 1996-07-31 2002-12-11 Otsuka Pharma Co Ltd Thiazole derivatives, their production and use
TR200001312T2 (tr) 1997-11-10 2000-09-21 Bristol-Myers Squibb Company Benzotiyazol protein tirozin kinaz önleyicileri.
EP0928793B1 (en) * 1998-01-02 2002-05-15 F. Hoffmann-La Roche Ag Thiazole derivatives
AU3406599A (en) * 1998-04-09 1999-11-01 Institut Fur Diagnostikforschung Gmbh An Der Freien Universitat Berlin Novel benzyl guanidine derivatives for therapy and (in-vivo) and (in-vitro) diagnosis
EP1797878A3 (en) 2000-06-21 2010-01-20 F. Hoffmann-La Roche AG Benzothiazole derivatives
US6599901B1 (en) * 2001-11-19 2003-07-29 Hoffman-La Roche Inc. Pyridone substituted benzothiazole derivatives
US6620811B2 (en) * 2001-11-19 2003-09-16 Hoffmann-La Roche Inc. Isonicotin- and nicotinamide derivatives of benzothiazoles
US6624163B2 (en) 2001-11-29 2003-09-23 Hoffman-La Roche Inc. Benzothiazole derivatives
GB0130868D0 (en) * 2001-12-24 2002-02-06 Univ Strathclyde New compounds
CN100357283C (zh) * 2002-04-02 2007-12-26 中国科学院上海药物研究所 一类甲硫氨酰氨肽酶抑制剂
US7087761B2 (en) 2003-01-07 2006-08-08 Hoffmann-La Roche Inc. Cyclization process for substituted benzothiazole derivatives
JP4408291B2 (ja) * 2003-05-13 2010-02-03 エフ．ホフマン−ラ ロシュ アーゲー アデノシン受容体リガンドとしての２−イミダゾ−ベンゾチアゾール
RU2351597C2 (ru) * 2003-05-19 2009-04-10 Ф.Хоффманн-Ля Рош Аг Производные бензотиазола в качестве лигандов аденозиновых рецепторов
DE602004004776T2 (de) * 2003-05-21 2007-11-22 F. Hoffmann-La Roche Ag Benzothiazol derivate und ihre anwendung in der behandlung von adenosin a2a rezeptor vermittelten krankheiten #
KR100765566B1 (ko) * 2003-05-30 2007-10-09 에프. 호프만-라 로슈 아게 벤조티아졸 유도체 및 아데노신 ａ２ａ 수용체와 관련된질병의 치료에서의 이들의 용도
SG130192A1 (en) * 2003-07-28 2007-03-20 Janssen Pharmaceutica Nv Benzimidazole, benzthiazole and benzoxazole derivatives and their use as lta4h modulators
BRPI0511543B1 (pt) 2004-05-24 2022-05-10 F. Hoffmann-La Roche Ag. Ácido 4-hidróxi-4-metila-piperidina-1-carboxílico (4-metóxi-7-morfolin-4-il-benzotiazol-2-il)- amida, seu processo de preparação, uso e medicamento que o compreende
BRPI0513510A (pt) * 2004-07-22 2008-05-06 Hoffmann La Roche benzotiazóis substituìdos
RU2382782C2 (ru) * 2004-07-22 2010-02-27 Ф. Хоффманн-Ля Рош Аг Производные бензотиазола
WO2006048172A1 (en) 2004-11-05 2006-05-11 F. Hoffmann-La Roche Ag Process for preparation of isonicotinic acid derivatives
RU2412943C2 (ru) 2005-03-23 2011-02-27 Ф. Хоффманн-Ля Рош Аг ПРОИЗВОДНЫЕ АЦЕТИЛЕНИЛ-ПИРАЗОЛО-ПИРИМИДИНА В КАЧЕСТВЕ АНТАГОНИСТОВ mGluR2
KR101121292B1 (ko) 2005-09-27 2012-04-13 에프. 호프만-라 로슈 아게 Ｍｇｌｕｒ2 길항제로서 옥사다이아졸일 피라졸로-피리미딘
EP1994017A2 (en) * 2006-03-15 2008-11-26 4Sc Ag Novel heterocyclic nf-kb inhibitors
GB0619325D0 (en) 2006-09-30 2006-11-08 Univ Strathclyde New compounds
WO2010008847A2 (en) * 2008-06-24 2010-01-21 Takeda Pharmaceutical Company Limited Pi3k/m tor inhibitors
US9499790B2 (en) 2010-08-26 2016-11-22 Kyoto University Method for promoting differentiation of pluripotent stem cells into cardiac muscle cells
SG11201401084TA (en) * 2011-09-30 2014-04-28 Kineta Inc Anti-viral compounds
WO2013111875A1 (ja) 2012-01-27 2013-08-01 国立大学法人京都大学 多能性幹細胞の心筋分化誘導法
EP2966166B1 (en) 2013-03-08 2019-04-03 Kyoto University Promoter of differentiation of pluripotent stem cell into myocardium, which comprises egf receptor inhibitor
JP6333830B2 (ja) * 2013-09-13 2018-05-30 国立大学法人京都大学 多能性幹細胞の心筋分化を促進する化合物
JP6651218B2 (ja) 2014-05-30 2020-02-19 国立大学法人京都大学 低分子化合物を用いた多能性幹細胞の心筋分化誘導法
CN109776486A (zh) * 2019-02-26 2019-05-21 武汉松石科技股份有限公司 一种硫酸亚丙酯的制备方法
CN110590735B (zh) * 2019-09-30 2021-07-23 江苏国泰超威新材料有限公司 一种环状硫酸酯的制备方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS61225168A (ja) * 1985-03-30 1986-10-06 Nippon Tokushu Noyaku Seizo Kk 新規ベンズアミド、その製法及び殺虫剤
KR930005004B1 (ko) * 1985-04-15 1993-06-11 쟈안센 파아마슈우티카 엔. 부이. 치환된 n-[(4-피페리디닐)알킬]이환 축합 옥사졸아민 및 티아졸아민의 제조방법
GB8611606D0 (en) * 1986-05-13 1986-06-18 Fbc Ltd Fungicides

Also Published As

Publication number Publication date
PL279613A1 (en) 1989-11-27
SU1681728A3 (ru) 1991-09-30
JPH0217181A (ja) 1990-01-22
HU202507B (en) 1991-03-28
DE68902358T2 (de) 1992-12-10
MX173140B (es) 1994-02-02
MX16158A (es) 1993-06-01
CN1037898A (zh) 1989-12-13
ATE79114T1 (de) 1992-08-15
NO172389C (no) 1993-07-14
FI892498A7 (fi) 1989-11-25
GR3005844T3 (esLanguage) 1993-06-07
PT90622B (pt) 1994-10-31
DK249389D0 (da) 1989-05-23
ZA893862B (en) 1991-01-30
MY106035A (en) 1995-03-31
HUT51606A (en) 1990-05-28
NO892059L (no) 1989-11-27
CN1023700C (zh) 1994-02-09
NO172389B (no) 1993-04-05
YU47019B (sh) 1994-11-15
AU3509889A (en) 1989-11-30
IL90337A0 (en) 1989-12-15
FI892498A0 (fi) 1989-05-23
NO892059D0 (no) 1989-05-23
KR910006864B1 (ko) 1991-09-09
YU105989A (en) 1990-08-31
DE68902358D1 (de) 1992-09-10
CA1328871C (en) 1994-04-26
KR890017248A (ko) 1989-12-15
JPH0678331B2 (ja) 1994-10-05
PT90622A (pt) 1989-11-30
AU601905B2 (en) 1990-09-20
IE891667L (en) 1989-11-24
DK249389A (da) 1989-11-27
EP0343893A1 (en) 1989-11-29
PL154875B1 (en) 1991-09-30
NZ229234A (en) 1990-09-26
DD283815A5 (de) 1990-10-24
EP0343893B1 (en) 1992-08-05

Similar Documents

Publication Publication Date Title
ES2043012T3 (es) Derivados de carboxamidas aromaticas y heterociclicas como agentes antineoplasticos.
NL970024I1 (nl) Anti-tumor middelen.
FI893618A0 (fi) Aminometyloxooxazolidinylarylbensen -derivat anvaendbara saosom antibakteriella medel.
FI863189A7 (fi) Luun morfogeneettisiä aineita.
FI895953A7 (fi) Kasvainvastaisia aineita
FI882742L (fi) Vaordande medel och dessa innehaollande kompositioner.
NO883694D0 (no) Ny analog offsetkombinasjonsteknikk.
DE3875692D1 (de) Muster-verabreichungsanordnung.
FI943019A7 (fi) Terapeuttisia aineita
NO900790L (no) Melatoninanaloger.
ES2056180T3 (es) Nuevos derivados de 2'-halometiliden, 2'-eteniliden y 2'-etinil citidina.
FI884067L (fi) Avfaergningsmedel foer avfallspapper.
FI895447A7 (fi) Substituoidut terapeuttisina aineina käytettävät adeniinijohdannaiset
NO884833D0 (no) Maalrettede former av metyltritio-anti-tumormidler.
ATE82257T1 (de) Antiarrythmische derivate 1.
FI971278A0 (fi) Kasvainten vastaisia aineita
FI891467L (fi) Sjaelvstabiliserade dipeptidsoetningsmedel.
FI885360A7 (fi) Prolaekemedel med antitumoereffekt.
ATE57526T1 (de) P-acylaminobenzamide.
IT1222867B (it) Ftalazino derivati ad attivita' farmaceutica
FI881894A7 (fi) Garvmedel.
FI881893L (fi) Garvmedel.
FI950101A0 (fi) 4-oksa-1-atsabisyklo 3,2,0 -7heptanoni-johdannaiset kasvainten vastaisina aineina
IT1227884B (it) Attivatore per osteoblasto
FI882382A7 (fi) Biostimulerande matsmaeltningsmedel och foerfarande foer framstaellning daerav.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 343893

Country of ref document: ES